Figure 4From: Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis Odds ratios of diabetic retinopathy associated with PAI-1 polymorphism (4G/4G versus 5G/5G) in average diabetes duration > 10 years.Back to article page